Xilio Therapeutics Inc (XLO) USD0.0001
1.03%- This stock can be held in a
Stocks and Shares ISASell:$1.26
Buy:$1.27
Change:
$0.20
(21.54%)
$0.20
(21.54%)Market closed | Prices delayed by at least 15 minutes
Sell:$1.26
Buy:$1.27
Change:$0.20
(21.54%)
$0.20
(21.54%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 December 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 6,092,816 | $1.04 | $6,335,919.36 | 9,975,266 |
| 18 December 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 1,759,978 | $1.04 | $1,830,377.12 | 9,105,451 |
| 2 April 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 485,250 | $0.76 | $368,790.00 | 7,345,473 |
| 2 April 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 3,882,450 | $0.76 | $2,950,273.76 | 3,882,450 |
| 27 March 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 6,860,223 | $1.97 | $13,514,639.31 | 6,860,223 |
| 8 February 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 733 | $0.64 | $469.12 | 2,019,563 |
| 8 February 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 267 | $0.64 | $170.88 | 734,546 |
| 12 January 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 1,540 | $0.83 | $1,278.20 | 2,020,296 |
| 12 January 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 560 | $0.83 | $464.80 | 734,813 |
| 11 January 2024 | LP ATLAS VENTURE FUND XIVenture Capital | Sell Regular sell transaction (market) | 1,566 | $0.87 | $1,362.42 | 2,021,836 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 27 March 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 6,860,223 | $1.97 | $13,514,639.31 | 6,860,223 |
| 18 December 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 6,092,816 | $1.04 | $6,335,919.36 | 9,975,266 |
| 2 April 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 3,882,450 | $0.76 | $2,950,273.76 | 3,882,450 |
| 18 December 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 1,759,978 | $1.04 | $1,830,377.12 | 9,105,451 |
| 2 April 2024 | GILEAD SCIENCES INCPublic Company | Buy Regular purchase transaction | 485,250 | $0.76 | $368,790.00 | 7,345,473 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.